Read a case study from the Division of Ophthalmology about pink eye, the detection of herpes simplex virus-1 (HSV-1) and the recurrence of HSV keratitis in children.

Midwest families, including patients treated while still in the womb, reunite with their Pennsylvania doctors and nurses.

The donation will to support the injury prevention programs at The Children's Hospital of Philadelphia. Since 2000, Kohl’s has donated more than $7.28 million to CHOP.

Genetic testing can help us better estimate risk for inhibitor formation, since inhibitors are more common with certain mutations causing hemophilia.

The Community Health and Literacy Center will offer healthcare, literacy and recreational services in one location for children and families in South Philadelphia.

CAS is a neurologically-based speech disorder in which there is a disruption in the motor planning for speech production, typically without muscle weakness.

Learn about how a new multicenter, surgical consortium is working to advance care and surgical treatment for children with bladder exstrophy.

The Cancer Center at CHOP invites the community to raise awareness and fund research to cure childhood cancer.

CHOP scientists altered red blood cells to produce a form of hemoglobin not affected by the mutation that causes sickle cell disease. The findings may lead to a new therapy for the disease.

Specialists at CHOP's Center for Fetal Diagnosis and Treatment report on 100 recent cases of fetal surgery for spina bifida, achieving results similar to the landmark clinical trial that established a new standard of care for prenatal repair of spina bifida.